HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA-class 1 and class 2 antigens in Turkish patients with pemphigus.

AbstractBACKGROUND:
Pemphigus is an autoimmune disease which is more frequently seen in certain ethnic groups such as Jews. It is thought that exogenous factors may induce pemphigus in genetically predisposed individuals. Recent reports on HLA antigens indicate an increased frequency of HLA-class II antigens particularly HLA-DR4 among Jewish patients. Herein we investigated the antigen frequencies of HLA-A, B, C, HLA-DR and DQ in Turkish patients with pemphigus.
METHODS:
HLA class I and II antigens were typed by microdroplet lymphocyte cytotoxicity test in 33 patients with pemphigus and 100 healthy individuals.
RESULTS:
HLA-B35, B44, CW4, DR4, DR14, DQ8 and DQ4 antigens were significantly high in the study group whereas HLA-DR11, DQ7 and DQ2 antigens were high among the controls. The most striking differences were observed in HLA class II antigens. HLA DR14-DQ8 and HLA B35-DR14 haplotypes were the most frequently observed ones in the study group.
CONCLUSIONS:
We postulate that HLA-B35, B44, CW4, DR4, DR14, DQ4 and DQ8 antigens may be responsible for susceptibility to pemphigus while HLA-DR11, DQ7 and DQ2 antigens may have a protective role in the Turkish population.
AuthorsAhu Birol, Rana Yavuzer Anadolu, Hüseyin Tutkak, Erbak Gürgey
JournalInternational journal of dermatology (Int J Dermatol) Vol. 41 Issue 2 Pg. 79-83 (Feb 2002) ISSN: 0011-9059 [Print] England
PMID11982641 (Publication Type: Journal Article)
Chemical References
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
Topics
  • Adult
  • Aged
  • Female
  • Gene Frequency (genetics)
  • Genetic Predisposition to Disease (genetics)
  • Haplotypes (genetics)
  • Histocompatibility Antigens Class I (genetics)
  • Histocompatibility Antigens Class II (genetics)
  • Humans
  • Linkage Disequilibrium (genetics)
  • Male
  • Middle Aged
  • Pemphigus (epidemiology, genetics)
  • Turkey (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: